- Title: Two scientists from U.S. and one from Britain share Nobel Medicine Prize
- Date: 7th October 2019
- Summary: STOCKHOLM, SWEDEN (OCTOBER 7, 2019) (REUTERS) (SOUNDBITE) (English) SECRETARY OF THE NOBEL ASSEMBLY, THOMAS PERLMANN, SAYING: "The Nobel Assembly at the Karolinska Institute has today decided to award the 2019 Nobel Prize in Physiology or Medicine jointly to William Kaelin, Sir Peter Ratcliffe and Gregg Semenza for their discoveries of how cells sense and adapt to oxygen availability."
- Embargoed: 21st October 2019 13:28
- Keywords: Nobel medicine William Kaelin Sir Peter Ratcliffe Gregg Semenza oxygen
- Location: STOCKHOLM, SWEDEN
- City: STOCKHOLM, SWEDEN
- Country: Sweden
- Topics: Arts / Culture / Entertainment
- Reuters ID: LVA001B03LC93
- Aspect Ratio: 16:9
- Story Text: Two scientists from the United States and one from Britain won the 2019 Nobel Medicine Prize on Monday (October 7) for finding how cells adapt to fluctuating oxygen levels, paving the way for new strategies to fight diseases such as anaemia and cancer.
The Nobel award-giving body said U.S.-born researchers William Kaelin and Gregg Semenza shared the prize equally with Peter Ratcliffe, who was born in Britain.
"The seminal discoveries by this year's Nobel laureates revealed the mechanism for one of life's most essential adaptive processes," the Nobel Assembly at Sweden's Karolinska Institute said in a statement on awarding the prize of 9 million Swedish crowns (913,000 U.S. dollar).
Their research established the basis for the understanding of how oxygen levels affect cellular metabolism and physiological functions, the institute said.
Medicine is the first of the Nobel Prizes awarded each year. The prizes for achievements in science, peace and literature have been awarded since 1901 and were created in the will of dynamite inventor and businessman Alfred Nobel.
(Production: Bjorn Lockstrom, Ilze Filks) - Copyright Holder: REUTERS
- Copyright Notice: (c) Copyright Thomson Reuters 2019. Open For Restrictions - http://about.reuters.com/fulllegal.asp
- Usage Terms/Restrictions: None